Literature DB >> 2110844

Effects of long-term theophylline treatment on adenosine A1-receptors in rat brain: autoradiographic evidence for increased receptor number and altered coupling to G-proteins.

J Fastbom1, B B Fredholm.   

Abstract

The effects of 2 weeks' treatment with theophylline (20 mg/kg i.p.) on the binding to adenosine A1-receptors was studied by autoradiography using the agonist [3H]N6-cyclohexyladenosine ([3H]CHA) and the antagonist [3H]8-cyclopentyl-1,3-dipropylxanthine ([3H]DPCPX) as ligands. A significant increase (10%) in [3H]CHA binding was measured only in the frontoparietal cortex. However, if the brain sections were incubated in the presence of 5 microM guanosine-5'-triphosphate (GTP), which by itself decreased binding by between 15 and 80% depending on the region, the increase in the frontoparietal cortex was larger (30%) and significant increases of the same magnitude were also seen in several other structures, e.g. the caudate putamen and the central gray matter of the midbrain. In some regions, for example the hippocampus and the cerebellar cortex, small or no increases were seen. GTP 100 microM practically eliminated [3H]CHA binding in both control and treated animals, suggesting that these receptors are all coupled to G-proteins. The binding of [3H]DPCPX was increased significantly only in the frontoparietal and striate cortex (5-10%). These results suggest that the theophylline treatment had little on the total receptor number but may have altered the coupling between A1-receptors and regulatory GTP-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110844     DOI: 10.1016/0006-8993(90)90272-d

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Changes in the biochemical profiles of mid-cervically located adenosine A1 receptors after repeated theophylline administration in adult rats.

Authors:  Rubabe S Saharan; Kwaku D Nantwi
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

2.  Modulation of the dinucleotide receptor present in rat midbrain synaptosomes by adenosine and ATP.

Authors:  M Díaz-Hernández; J Pintor; M T Miras-Portugal
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Desensitization of adenosine A1 receptor-mediated inhibition of adenylyl cyclase in cerebellar granule cells.

Authors:  D Vendite; J M Sanz; D M López-Alañon; J Vacas; A Andrés; M Ros
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

4.  Modulation of cardiac A1-adenosine receptors in rats following treatment with agents affecting heart rate.

Authors:  Nissim Balas; Michael Arad; Babeth Rabinowitz; Asher Shainberg
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

5.  Effects of theophylline and dibutyryl-cAMP on adenosine receptors and heart rate in cultured cardiocytes.

Authors:  D el-Ani; K A Jacobson; A Shainberg
Journal:  J Basic Clin Physiol Pharmacol       Date:  1996

Review 6.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

7.  Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia.

Authors:  D K Von Lubitz; R C Lin; N Melman; X D Ji; M F Carter; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1994-04-21       Impact factor: 4.432

Review 8.  Recovery of respiratory activity after C2 hemisection (C2HS): involvement of adenosinergic mechanisms.

Authors:  Kwaku D Nantwi
Journal:  Respir Physiol Neurobiol       Date:  2009-08-03       Impact factor: 1.931

9.  Mice heterozygous for both A1 and A(2A) adenosine receptor genes show similarities to mice given long-term caffeine.

Authors:  Jiang-Ning Yang; Olga Björklund; Karin Lindström-Törnqvist; Eva Lindgren; Therese M Eriksson; Johan Kahlström; Jiang-Fan Chen; Michael A Schwarzschild; Irene Tobler; Bertil B Fredholm
Journal:  J Appl Physiol (1985)       Date:  2008-11-26

10.  Adenosine A3 receptor stimulation and cerebral ischemia.

Authors:  D K Von Lubitz; R C Lin; P Popik; M F Carter; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1994-09-22       Impact factor: 4.432

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.